Cyberounds Logo
September 23, 2020 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
Non-Small Carcinoma of the Lung
CME credit is no longer available for this conference.
Robert G. Lerner, M.D.

In the past three years, Dr. Lerner has served as a consultant for RPR, and has served on the Speakers' Bureau for Pharmacia & Upjohn.


Release Date: 09/28/2002
Termination Date: 09/28/2005

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Understand the meaning of the term "non-small cell lung cancer" (NSCLC)
  • Discuss The Revised International Staging System for Lung Cancer
  • Discuss the therapeutic options -- surgery, radiation or chemotherapy -- and their effectiveness vis a vis this disease
  • List the many different chemotherapeutic agents that are effective for this group of tumors
  • Recognize that although palliation and prolongation of survival can be achieved, even in far advanced or recurrent cases, there is no single standard regimen and participation in trials should be considered.

 
This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity